Breaking News, Collaborations & Alliances

BioMed X, Merck KGaA Launch Research and Bio-Mfg. Projects

Aims to identify novel approaches for targeted cancer therapy and better ways to manufacture monoclonal antibodies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

BioMed X has launched two new global calls for application together with Merck KGaA in Darmstadt in the fields of RNA splicing in cancer and engineering of high-performance production cell lines. Scientists from top universities and research institutions are invited to submit innovative project proposals and apply for a research fellowship at the BioMed X Innovation Center in Heidelberg, Germany. BioMed X was founded in 2013 in collaboration with Merck KGaA and its innovation model has attra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters